The spread of cancer cells to draining lymph nodes is an important pro
gnostic factor for many cancers and influences postoperative therapy i
n patients. Histopathology is used routinely to assess if lymph nodes
contain metastases. There are, however, time and resource constraints
on the volume of lymph node tissue that can be examined by the patholo
gist in a routine laboratory (less than 2% of each node), thus major s
ampling errors are possible. Conventional histopathology also relies o
n identifying aggregates of malignant cells for a positive diagnosis.
Proton (H-1) magnetic resonance (MR) spectroscopy can detect chemical
changes, specifically increased levels of lactate, choline, fucose and
amino acids, in lymph nodes infiltrated by cancer. Increase in lactat
e indicates the presence of anaerobically respiring cells, whereas cho
line reports that the cells are replicating. Since MR spectroscopy can
identify early infiltration by malignant cells, before cell clusters
are visible under the light microscope, it detects micrometastases in
lymph nodes missed histopathologically. Furthermore, MR spectroscopy e
liminates sampling errors since the entire lymph node is examined.